Old Web
English
Sign In
Acemap
>
authorDetail
>
William D. Carter
William D. Carter
Sharp Memorial Hospital
Medicine
Lymphoma
Immunology
Keyhole limpet hemocyanin
Non-Hodgkin's lymphoma
3
Papers
115
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
PR-104 plus sorafenib in patients with advanced hepatocellular carcinoma.
2011
Cancer Chemotherapy and Pharmacology
Ghassan K. Abou-Alfa
Stephan L. Chan
Chia-Chi Lin
E. Gabriela Chiorean
Randall F. Holcombe
Mary Frances Mulcahy
William D. Carter
Kashyap Patel
William R. Wilson
Teresa J. Melink
John Gutheil
Chao Jung Tsao
Show All
Source
Cite
Save
Citations (22)
A phase 2 trial of immunotherapy with mitumprotimut-T (Id-KLH) and GM-CSF following rituximab in follicular B-cell lymphoma.
2010
Journal of Immunotherapy
Omer N. Koc
Charles H. Redfern
Peter H. Wiernik
Fred Rosenfelt
Jane N. Winter
William D. Carter
Dan P. Gold
Morgan E. Stewart
Richard G. Ghalie
John F. Bender
Show All
Source
Cite
Save
Citations (8)
Phase II Trial of Idiotype Vaccination in Previously Treated Patients With Indolent Non-Hodgkin’s Lymphoma Resulting in Durable Clinical Responses
2006
Journal of Clinical Oncology
Charles H. Redfern
Troy H. Guthrie
Alberto Bessudo
John J. Densmore
Peter R. Holman
Nalini Janakiraman
John P. Leonard
Richard L. Levy
Richard G. Just
Mitchell R. Smith
Fred Rosenfelt
Peter H. Wiernik
William D. Carter
Daniel P. Gold
Teresa Melink
John Gutheil
John F. Bender
Show All
Source
Cite
Save
Citations (85)
1